Discontinuation of Antidepressant Medication Among Latinos in the USA

Heller School for Social Policy and Management, Brandeis University, Волтам, Massachusetts, United States
The Journal of Behavioral Health Services & Research (Impact Factor: 1.37). 08/2007; 34(3):329-42. DOI: 10.1007/s11414-007-9070-6
Source: PubMed


Despite recent growth in the variety of antidepressant medications available, many patients discontinue medication prematurely for reasons such as nonresponse, side effects, stigma, and miscommunication. Some analysts have suggested that Latinos may have higher antidepressant discontinuation rates than other US residents. This paper examines Latino antidepressant discontinuation, using data from a national probability survey of Latinos in the USA. In this sample, 8% of Latinos had taken an antidepressant in the preceding 12 months. Among those users, 33.3% had discontinued taking antidepressants at the time of interview, and 18.9% had done so without prior input from their physician. Even controlling for clinical and other variables, patients who reported good or excellent English proficiency were less likely to stop at all. Patients were also less likely to stop if they were older, married, had public or private insurance, or had made eight or more visits to a nonmedical therapist.

Download full-text


Available from: Margarita Alegria, Oct 10, 2014
  • Source
    • "Excluded from this table are the results of review studies and the original articles of Edlund et al. (2008); Einarson (2009); Hirschfeld (1998); Hirschfeld et al. (1997); Schraufnagel et al. (2006); Meredith et al. (2009); and Hodgkin et al. (2007). "
    [Show abstract] [Hide abstract]
    ABSTRACT: The aim of this study was to ascertain whether there is any evidence of stigma related to the use of antidepressants. Using the PubMed and MEDLINE databases, we searched for the terms stigma, antidepressants, and depression. A protocol was developed to extract information from the papers, which were identified and explored further. Thirty-two papers were identified. We found that the stigma against depression differs from stigma against the use of antidepressants. Stigma against depression does not impact on therapeutic adherence to antidepressant use. Stigma related to antidepressant use appears to be linked with perceived emotional weakness, severity of illness, an inability to deal with problems, and a lack of belief in the therapeutic efficacy of antidepressants. Stigma against medication can be a useful target for interventions, just like the stigma related to depression. However, clinicians must be careful in avoiding the medicalization of symptoms.
    The Journal of nervous and mental disease 11/2011; 199(11):866-71. DOI:10.1097/NMD.0b013e3182388950 · 1.69 Impact Factor
  • Source
    • "Other predictors of poor adherence cannot be modified by treating clinicians. Examples of the latter include low level of education81 and/or poor English-language proficiency,23 psychosocial immaturity,122,123 and disadvantaged economic23,82,124 and/or family functioning123–125 circumstances. Although clinicians always should communicate in a clear, easily understood manner,47,53 this is especially necessary in situations where the latter adverse predictors are prominent. "
    [Show abstract] [Hide abstract]
    ABSTRACT: When treatments are ordered for adolescent major depression, or for other adolescent medical illnesses, adherence and clinical outcomes are likely to be unsatisfactory, unless 4 basic principles of the medical treatment of adolescent illness are implemented. These comprise providing effective patient and parent/caregiver education, establishing effective patient and caregiver therapeutic alliances, providing effective treatment, and managing other factors associated with treatment adherence as indicated. The goals of treatment are to achieve the earliest possible response and remission. Failure to treat adolescent major depression successfully has potentially serious consequences, including worsened adherence, long-term morbidity, and suicide attempt. Accordingly, prescribed treatment must be aggressively managed. Doses of an antidepressant medication should be increased as rapidly as can be tolerated, preferably every 1-2 weeks, until full remission is achieved or such dosing is limited by the emergence of unacceptable adverse effects. A full range of medication treatment options must be employed if necessary. Treatment adherence, occurrence of problematic adverse effects, clinical progress, and safety must be systematically monitored. Adolescents with major depression must be assessed for risk of harm to self or others. When this risk appears significant, likelihood of successful outcomes will be enhanced by use of treatment plans that comprehensively address factors associated with treatment nonadherence. Abbreviated and comprehensive plans for the treatment of potentially fatal adolescent illnesses are outlined in this review.
    Adolescent Health, Medicine and Therapeutics 08/2010; 1:73-85. DOI:10.2147/AHMT.S8791
  • Source
    • "Although US studies about stigma in Latino patient populations are very few and mostly exploratory, the evidence is highly suggestive. Both quantitative and qualitative reports underscore concerns, especially among foreign-born and less acculturated Latinos, regarding labeling, embarrassment and social discrimination from family, friends and employers impeding acceptance of depression treatment and medication adherence [12] [13] [14]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: To develop a validated stigma checklist to assist physicians in addressing depression in Latino patients. Two hundred low-income, Spanish-speaking, Latino patients in primary care clinics were screened for depression using Patient Health Questionnaires (PHQ-2 and PHQ-9), and medical records were reviewed. With the use of a wide pool of stigma items, empirical methods were used to develop a stigma checklist from this primary care sample and patient information was used to demonstrate construct validity. Patients reporting higher levels of perceived stigma using the stigma checklist were less likely to disclose their depression diagnosis to their family and friends (P<.05) and also less likely to be taking depression medication (OR=.78; 95% CI, .62-.99). Patients with stigma were less likely to be able to manage their depression (OR=.79; 95% CI, .65-.96) and more likely to have missed scheduled appointment visits (OR=1.44; 95% CI, 1.03-2.02). Given the strong relationship between stigma and care of depression, primary care clinicians should be aware of and address stigma among their depressed Latino patients. The stigma checklist presented for treating Spanish-speaking Latino patients in primary care may be used to assess depressed patients for stigma to help inform clinical management of patients.
    General hospital psychiatry 03/2010; 32(2):182-91. DOI:10.1016/j.genhosppsych.2009.10.008 · 2.61 Impact Factor
Show more